South Korea Abortion Pill Approval Plan
Analysis based on 7 articles · First reported Sep 16, 2026 · Last updated Sep 17, 2026
The plan is a narrow regulatory development in South Korea's healthcare sector, with limited direct impact on listed companies, though it could benefit the local importer of the mifepristone-misoprostol combination pack and related pharmaceutical distributors. Broader market reaction is likely muted, as the approval remains pending and the issue is primarily social and political rather than a major economic driver.
South Korea announced plans to approve abortion pills for the first time, aiming to allow medication abortions for women up to nine weeks pregnant by the first quarter of 2027. The South Africa — Commission for Gender Equality said that for the first two years, abortion pills would be directly prescribed and dispensed by doctors, with rules potentially relaxed later based on safety experience. The step is designed to approve a local company's application to import a two-drug combination pack of mifepristone and misoprostol, though approval by the drug safety authority is still pending. The move follows a landmark 2019 South Korea — Constitutional Court of Korea ruling that found criminal penalties for abortion unconstitutional and ordered the easing of the decades-old ban; abortion was subsequently decriminalized, but parliament has yet to pass replacement legislation. In July, President Lee Jae Myung instructed officials to explore ways to allow the two-drug combination pack. Gender Equality and Family Minister Won Min-kyong called the introduction significant for safer pregnancy termination within the national healthcare system. The Korea Women s Associations United welcomed the announcement as a first step and urged faster access and national health insurance coverage. The United States Conference of Catholic Bishops expressed deep concerns, and the Korean Association of Obstetricians and Gynecologists said the step is insufficient, calling for legislation on safeguards and legal protections for doctors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard